IC SURGICAL


Associated tags: Surgery, Health, Oncology, Patient satisfaction, Aesthetics, Research, Trial of the century, Plastic and Reconstructive Surgery, Mastectomy, Medical director, Patient, Safety, Breast cancer, Wound healing, Medical imaging, Seroma

Locations: MICHIGAN, UNITED STATES, NORTH AMERICA

IC Surgical, Inc. Announces Breakthrough Clinical Study Published Reporting Improved Outcomes in Breast Cancer Patients Undergoing Post-Mastectomy Breast Reconstruction with Novel Interi® System

Retrieved on: 
Thursday, September 21, 2023
Surgery, Health, Oncology, Patient satisfaction, Aesthetics, Research, Trial of the century, Plastic and Reconstructive Surgery, Mastectomy, Medical director, Patient, Safety, Breast cancer, Wound healing, Medical imaging, Seroma

IC Surgical, Inc., an innovator in surgical technologies, announces the independent publication of a groundbreaking clinical study showcasing the success of the Interi™ System in breast reconstruction.

Key Points: 
  • IC Surgical, Inc., an innovator in surgical technologies, announces the independent publication of a groundbreaking clinical study showcasing the success of the Interi™ System in breast reconstruction.
  • This pivotal research, "Reduction in Seroma and Other Complications with a Novel Internal Negative Pressure System in Breast Reconstruction", offers compelling evidence of the Interi System's effectiveness in reducing complications compared to traditional drains.
  • The study, recently published in Plastic and Reconstructive Surgery Global Open in September 2023, demonstrates the potential for the Interi System to significantly improve outcomes for breast cancer patients undergoing post-mastectomy breast reconstruction.
  • In the study, author Dr. Robert Paul evaluated the safety and efficacy of the Interi System compared to standard drains in 200 prepectoral breast reconstructions patients, in two well-matched cohorts.